creatine has been researched along with Anorexia in 1 studies
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multiple pilot studies, including one in colorectal cancer patients, suggest that creatine, an amino acid derivative, augments muscle, improves strength, and thereby could palliate the cancer anorexia/weight loss syndrome." | 9.24 | A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. ( Adonizio, CS; Atherton, PJ; Jaslowski, AJ; Jatoi, A; Le-Lindqwister, NA; Loprinzi, C; Moore, DF; Rowland, KM; Sloan, J; Steen, PD, 2017) |
| "Multiple pilot studies, including one in colorectal cancer patients, suggest that creatine, an amino acid derivative, augments muscle, improves strength, and thereby could palliate the cancer anorexia/weight loss syndrome." | 5.24 | A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. ( Adonizio, CS; Atherton, PJ; Jaslowski, AJ; Jatoi, A; Le-Lindqwister, NA; Loprinzi, C; Moore, DF; Rowland, KM; Sloan, J; Steen, PD, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jatoi, A | 1 |
| Steen, PD | 1 |
| Atherton, PJ | 1 |
| Moore, DF | 1 |
| Rowland, KM | 1 |
| Le-Lindqwister, NA | 1 |
| Adonizio, CS | 1 |
| Jaslowski, AJ | 1 |
| Sloan, J | 1 |
| Loprinzi, C | 1 |
1 trial available for creatine and Anorexia
| Article | Year |
|---|---|
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.
Topics: Aged; Anorexia; Creatine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Placebo | 2017 |